ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc. (LifeMap), a subsidiary of BioTime, Inc., announced today a commercial partnership agreement with Toldot Genetics, LTD (Toldot), a subsidiary of BATM Advanced Communications, Ltd. LifeMaps GeneCards Suite, comprised of the companys integrated biomedical knowledgebase and premium analysis tools, will optimize Toldots next generation sequencing (NGS) data analysis capabilities by powering its algorithm-based tools for assigning genetic variations derived from whole genome and exome sequencing, to clinical conditions in order to improve biomedical research. LifeMap will also promote Toldots products and offer them to its large user base of life scientists in academia, research hospitals, and biopharma.

LifeMap Sciences extensive integrated biomedical knowledgebase will further expand Toldots analysis systems in order to contribute to the ability to get the most of unprecedented quantities of gene-related data derived from NGS experiments, said Yaron Guan-Golan, Chief Marketing Officer of LifeMap Sciences. Our partnership with Toldot Genetics reflects the flexibility of our technology to enhance biomedical research and discovery.

We believe that combining LifeMaps comprehensive biomedical knowledgebase and advanced analysis tools with Toldots proven ability to extract the most relevant information out of large amounts of sequencing data will create the best NGS analysis package available on the market today, said Dvir Dahary, CEO of Toldot Genetics. This partnership will assist in the discovery of novel clinical and scientific insights.

LifeMaps cloud-based technology offers unlimited access to users who wish to use its integrated biomedical knowledgebase and premium tools VarElect and GeneAnalytics for NGS data analysis. The company is also offering partners who are developing and commercializing NGS analysis platforms access to its integrated knowledgebase and tools under various business arrangements.

Both VarElect and GeneAnalytics are part of LifeMap Sciences recently launched GeneCards Suite Premium Tools. The tools leverage the LifeMap integrated biomedical knowledgebase, which includesGeneCards, the leading human gene database, MalaCards, the human disease database, andLifeMap Discovery, the cells and tissues database. LifeMap holds the exclusive worldwide license to marketGeneCards,MalaCards, VarElect, GeneAnalytics and GenAlaCart from Yeda Research and Development Company Ltd., the commercial arm of the Weizmann Institute of Science.

About LifeMap Sciences, Inc.

LifeMap Sciences (www.lifemapsc.com) is a life sciences technology company that offers integrated, streamlined solutions that empower life scientists worldwide to conduct cutting edge basic, clinical, and applied biomedical research.LifeMaps products are used in more than 3,000 institutions including academia, research hospitals, patent offices, and leading biopharma. The companys primary product offering, the GeneCards Suite, is comprised of an integrated biomedical knowledgebase and premium tools that enable researchers to effectively navigate the universe of human genes, proteins, cells, biological pathways, diseases, and the relationships between them. The knowledgebase includes three key databases that integrate information from over 100 sources: GeneCards, the leading human gene database, MalaCards, the human disease database, and LifeMap Discovery, the cells and tissues database. The GeneCards Suite premium tools are a set of biomedical data analysis applications that leverage the GeneCards Suite knowledgebase for gene variant prioritization and RNAseq and microarray gene set analysis to deliver enhanced results, including from the unprecedented quantities of data derived from Next Generation Sequencing (NGS). The premium tools include VarElect, the NGS phenotyper,GeneAnalytics, a novel gene set analysis tool, and GeneALaCart, the GeneCards batch querying application. LifeMap Sciences intends to extend its offerings to the field of mobile health via its subsidiary,LifeMap Solutions, Inc. Operations worldwide are carried out from their offices in California, Massachusetts, New Jersey, Tel Aviv and Hong Kong. LifeMap is a subsidiary of BioTime, Inc.

About Toldot Genetics Ltd.

Toldot Genetics (www.toldot-dna.com) improves healthcare through the use of whole genome sequencing, developing and applying sophisticated algorithm-based tools and approaches to assign genetic variations to clinical conditions. Toldot provides geneticists and physicians with a complete analysis package of Exome sequencing data for identifying the causal mutations of rare genetic disorders. Pharma and BioTech companies use Toldot's services in their clinical pipelines, from the design and all the way to deep analysis of their sequencing data, exclusively tailored for the requirements of each project, incorporating gold-standard tools with in-house algorithms and software.

About BATM Ltd.

See original here:

LifeMap Sciences Partners with Toldot Genetics to Support Next Generation Sequencing Variant Analysis Commercialization